Alnylam Pharmaceuticals
ALNY
#547
Rank
A$64.29 B
Marketcap
A$486.64
Share price
-2.52%
Change (1 day)
8.91%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company